HPV16 non HLA-restricted t-cell vaccines, compositions and methods of use thereof
US11401306B2 · kind B2 · utility
7Cited by
2References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 4, 2017 |
| Grant date | Aug 2, 2022 |
| Priority date | — |
| Expiry date | Oct 4, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2710/20071
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel human papillomovirus immunogenic compositions and methods of use thereof are provided. The compositions comprise unique combinations of multi-epitope peptide sequences specifically selected and designed to be effectively processed and cross-presented to T-cells. The peptides utilized in the compositions display high levels of binding with HLA-supertypes. The immunogenic compositions are broadly applicable to large proportions of target populations. The compositions comprise adjuvants such as cationic lipids.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.